Fresenius Kabi AG Launches Kabiven® In The United States
LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today it has launched Kabiven® (amino acids, electrolytes, dextrose and lipid injectable emulsion) for intravenous use, with immediate availability. Kabiven is a parenteral nutrition (PN) product in a three-chamber bag – the only container of its kind approved in the United States. Fresenius Kabi is a global health care company that specializes in life-saving medicines and technologies for infusion, transfusion and clinical nutrition.
Kabiven was approved by the U.S. Food and Drug Administration in August. It is an intravenously infused solution of lipids, dextrose, amino acids and electrolytes in a three-chamber bag that efficiently delivers these nutrients in volumes and concentrations that meet the nutritional needs of most patients.
Help employers find you! Check out all the jobs and post your resume.
Kabiven was approved by the U.S. Food and Drug Administration in August. It is an intravenously infused solution of lipids, dextrose, amino acids and electrolytes in a three-chamber bag that efficiently delivers these nutrients in volumes and concentrations that meet the nutritional needs of most patients.
Help employers find you! Check out all the jobs and post your resume.